NCT07356648

Brief Summary

Carpal tunnel syndrome (CTS), first described by Paget in 1854, is the most common entrapment neuropathy. Conservative treatment approaches are prioritized in patients with mild to moderate CTS. Conservative management includes education, tendon and median nerve gliding exercises, physical therapy modalities, kinesiotaping, manual therapy techniques, injection options, and oral medical treatments. First-line treatment generally consists of education, exercise, and splinting. Tendon and median nerve gliding exercises represent key components of conservative treatment. Splinting is recommended at all stages of CTS, with wrist splints designed to maintain a neutral position being the most commonly preferred option. The prevailing approach in the literature supports the use of splints primarily during nighttime. Diadynamic current (DDC) is considered to have a composite analgesic mechanism, primarily explained by the gate control theory. Additional mechanisms suggest that DDC affects both sensory and motor nerves and may increase endorphin release, contributing to pain relief. A single treatment session typically does not exceed 12 minutes. Some studies indicate that the analgesic effect of DDC may be greater than that of transcutaneous electrical nerve stimulation (TENS). Although TENS is widely used in physical therapy and rehabilitation practice, DDC may represent a realistic alternative for clinical pain management. The aim of the study is to evaluate the effect of diadynamic current therapy on clinical symptoms in patients with CTS and to investigate its impact on electrophysiological findings of the median nerve.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 21, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2025

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

December 23, 2025

Completed
29 days until next milestone

First Posted

Study publicly available on registry

January 21, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

January 21, 2026

Status Verified

January 1, 2026

Enrollment Period

8 months

First QC Date

December 23, 2025

Last Update Submit

January 15, 2026

Conditions

Keywords

Carpal Tunnel SyndromeDiadynamic CurrentElectrotherapyPain

Outcome Measures

Primary Outcomes (7)

  • Change from Baseline in Boston Carpal Tunnel Questionnaire Symptom Severity Scale Score

    Boston Carpal Tunnel Questionnaire - Symptom Severity Scale (BCTQ-SSS) is a patient-reported outcome measure assessing symptom severity in individuals with carpal tunnel syndrome. Scores range from 1 to 5, with higher scores indicating worse symptom severity.

    Baseline and 6 weeks

  • Change from Baseline in Boston Carpal Tunnel Questionnaire Functional Status Scale Score

    Boston Carpal Tunnel Questionnaire - Functional Status Scale (BCTQ-FSS) assesses functional status and difficulty in daily activities in individuals with carpal tunnel syndrome. Scores range from 1 to 5, with higher scores indicating worse functional status.

    Baseline and 6 weeks

  • Change from Baseline in Hand Grip Strength (kg)

    Hand Grip Strength was measured using a Saehan SH5001 Hydraulic Hand Dynamometer and recorded in kg. Higher values indicate greater grip strength.

    Baseline and 6 weeks

  • Change from Baseline in Pinch Grip Strength (kg)

    Pinch Grip Strength was measured using a Saehan SH5005-1 Mechanical Pinch Gauge and recorded in kg. Higher values indicate greater pinch strength.

    Baseline and 6 weeks

  • Electrophysiological Assessment-Median Distal Motor Latency

    Median distal motor latency was evaluated using nerve conduction studies (NCS) performed at the Electromyography Laboratory of the Department of Neurology, Düzce University Faculty of Medicine. Measurements were recorded in milliseconds (ms). Electrophysiological carpal tunnel syndrome was defined as median distal motor latency ≥ 4.0 ms.

    Baseline and 6 weeks

  • Electrophysiological Assessment- Median Sensory Nerve Conduction Velocity

    Median sensory nerve conduction velocity was evaluated using nerve conduction studies (NCS) performed at the Electromyography Laboratory of the Department of Neurology, Düzce University Faculty of Medicine. Measurements were recorded in meters per second (m/s). Electrophysiological carpal tunnel syndrome was defined as median sensory nerve conduction velocity ≤ 40 m/s.

    Baseline and 6 weeks

  • Electrophysiological Assessment-Median-Ulnar Sensory Peak Latency Difference

    Comparative median-ulnar sensory peak latency analysis was performed using fourth-digit recordings with wrist stimulation during nerve conduction studies (NCS). Measurements were recorded in milliseconds (ms). Electrophysiological carpal tunnel syndrome was defined as median sensory peak latency from the fourth digit exceeding ulnar latency by ≥ 0.4 ms.

    Baseline and 6 weeks

Study Arms (2)

Group 1: Diadynamic Current Plus Splint

EXPERIMENTAL

Diadynamic current (DDC) is a routine physical therapy modality applied in the physical medicine and rehabilitation clinic to reduce symptoms in various conditions. In individuals with carpal tunnel syndrome (CTS), splinting is routinely prescribed as a first-line conservative treatment. In addition, physical therapy modalities such as DDC are applied in cases where adequate benefit is not achieved with splint therapy alone. Since splinting is provided as the initial conservative treatment in routine clinical practice, no delay or loss of treatment time occurs. Individuals receiving splint therapy are informed about DDC treatment, and those providing consent for 10 physical therapy sessions are allocated to the DDC group.

Procedure: Diadynamic Current

Group 2: Splint-Only Group

ACTIVE COMPARATOR

In individuals with carpal tunnel syndrome, splinting is routinely prescribed as a first-line conservative treatment.

Procedure: Diadynamic CurrentProcedure: Wrist Splint

Interventions

Diadynamic current (DDC) is a routine therapeutic modality applied in the physical medicine and rehabilitation clinic to alleviate symptoms in various conditions. In individuals with carpal tunnel syndrome (CTS), DDC is routinely administered in cases where sufficient benefit is not achieved with splinting and transcutaneous electrical nerve stimulation (TENS). For this purpose, diadynamic current is applied to the palmar surface of the hand and the volar surface of the forearm using equal-sized carbon electrodes (6 × 6 cm). A sequence of different types of diadynamic currents is administered for a total duration of 10 minutes as follows: diphase fixe (DF) for 2 minutes, monophase fixe (MF) for 3 minutes, longues périodes (LP) for 3 minutes, and courtes périodes (CP) for 2 minutes. The treatment duration, parameters, and sequence of diadynamic currents are based on Bernard's current methodology and are identical to the procedure described by Ratajczak et al.

Group 1: Diadynamic Current Plus SplintGroup 2: Splint-Only Group
Wrist SplintPROCEDURE

In individuals with carpal tunnel syndrome, splinting is routinely prescribed as a first-line conservative treatment. A resting wrist splint extending from the distal forearm to the hand and maintaining the wrist in a neutral position is provided to both groups. The splint is worn every night before bedtime, maintained throughout the night, and removed in the morning upon waking.

Group 2: Splint-Only Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinically and electrophysiologically diagnosed with carpal tunnel syndrome (CTS)
  • Provision of informed consent
  • Age between 18 and 65 years

You may not qualify if:

  • Age below 18 years or above 65 years
  • Median nerve distal motor latency \> 6.0 ms on nerve conduction studies (NCS)
  • Thenar muscle atrophy
  • History of carpal tunnel syndrome surgery
  • History of steroid injection into the carpal tunnel
  • History of physical therapy for CTS within the past 6 months
  • Cervical radiculopathy
  • Tenosynovitis in the ipsilateral upper extremity
  • Other compressive neuropathy in the ipsilateral upper extremity
  • Peripheral polyneuropathy
  • History of trauma or fracture involving the hand, wrist, or forearm
  • Pregnancy
  • Presence of metabolic disease
  • Inflammatory rheumatic disease
  • Acute and/or chronic renal failure
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Düzce University

Düzce, Turkey (Türkiye)

Location

Related Publications (2)

  • Demidas A, Zarzycki M. Touch and Pain Sensations in Diadynamic Current (DD) and Transcutaneous Electrical Nerve Stimulation (TENS): A Randomized Study. Biomed Res Int. 2019 Jul 17;2019:9073073. doi: 10.1155/2019/9073073. eCollection 2019.

  • Koca I, Boyaci A, Tutoglu A, Ucar M, Kocaturk O. Assessment of the effectiveness of interferential current therapy and TENS in the management of carpal tunnel syndrome: a randomized controlled study. Rheumatol Int. 2014 Dec;34(12):1639-45. doi: 10.1007/s00296-014-3005-3. Epub 2014 Apr 12.

MeSH Terms

Conditions

Carpal Tunnel SyndromePain

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and InjuriesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 23, 2025

First Posted

January 21, 2026

Study Start

April 21, 2025

Primary Completion

December 15, 2025

Study Completion

April 1, 2026

Last Updated

January 21, 2026

Record last verified: 2026-01

Locations